Lowest Value Trap Biological Products, (No Diagnostic Substances) Stocks 2026

Safest value Biological Products, (No Diagnostic Substances) stocks in 2026 with the lowest Value Trap scores. Avoid value traps with CirclFi's multi-signal screening.

119 stocks analyzed Updated 2026-05-29
# Ticker Company QOC Price Trap Score
1 GILD Gilead Sciences, Inc. 10.0 $134.43 5/100
2 AVXL Anavex Life Sciences Corp. 4.3 $3.03 6/100
3 CLLS Cellectis S.A. 2.5 $3.52 6/100
4 DNLI Denali Therapeutics Inc. 6.9 $21.04 6/100
5 EXEL Exelixis, Inc. 10.0 $50.48 6/100
6 FENC Fennec Pharmaceuticals Inc. 6.3 $9.93 6/100
7 IMCR Immunocore Holdings plc 8.2 $28.89 6/100
8 KRYS Krystal Biotech, Inc. 7.7 $309.03 6/100
9 NBIX Neurocrine Biosciences, Inc. 10.0 $158.30 6/100
10 PROK ProKidney Corp. 4.3 $1.83 6/100
11 V••• Vericel ••••• •.• $•••.•• ••.•%
12 I••• Inhibrx ••••• •.• $•••.•• ••.•%
13 M••• Moderna, ••••• •.• $•••.•• ••.•%
14 B••• Beam ••••• •.• $•••.•• ••.•%
15 C••• Compugen ••••• •.• $•••.•• ••.•%
16 C••• CG ••••• •.• $•••.•• ••.•%
17 C••• Cardiol ••••• •.• $•••.•• ••.•%
18 D••• Ginkgo ••••• •.• $•••.•• ••.•%
19 E••• enGene ••••• •.• $•••.•• ••.•%
20 E••• Estrella ••••• •.• $•••.•• ••.•%
🔒

Unlock the Full Lowest Value Trap Biological Products, (No Diagnostic Substances) Stocks 2026 List

Screen all 119 Biological Products, (No Diagnostic Substances) stocks with 13 institutional-grade valuation models. Updated daily from SEC EDGAR filings.

Access Full Screening — From $27/mo →

How CirclFi Ranks Biological Products, (No Diagnostic Substances) Stocks

CirclFi analyzes 119 Biological Products, (No Diagnostic Substances) stocks daily using 13 independent institutional-grade valuation models. Each model processes SEC EDGAR 10-K and 10-Q financial filings (700+ XBRL tags), FRED macroeconomic data, and GDELT news sentiment.

The lowest value trap biological products, (no diagnostic substances) stocks 2026 ranking uses trap score as the primary sort criterion. Models span intrinsic valuation (Bayesian DCF with 10,000 Monte Carlo simulations, EPV), scenario analysis (First Chicago), regime-switching (Markov DDM), and machine learning (ML-RIV, FTNN Topology).